Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) EBIT Margin: 2019-2024

Historic EBIT Margin for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to 4.82%.

  • Agilon Health's EBIT Margin rose 600.0% to 9.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.41%, marking a year-over-year decrease of 1900.0%. This contributed to the annual value of 4.82% for FY2024, which is 5600.0% up from last year.
  • As of FY2024, Agilon Health's EBIT Margin stood at 4.82%, which was up 5600.0% from 5.38% recorded in FY2023.
  • In the past 5 years, Agilon Health's EBIT Margin registered a high of 4.41% during FY2022, and its lowest value of 24.47% during FY2021.
  • Over the past 5 years, Agilon Health's median EBIT Margin value was 4.82% (recorded in 2024), while the average stood at 8.75%.
  • In the last 5 years, Agilon Health's EBIT Margin plummeted by -198100bps in 2021 and then surged by 200500bps in 2022.
  • Annual analysis of 5 years shows Agilon Health's EBIT Margin stood at 4.65% in 2020, then crashed by -426bps to 24.47% in 2021, then skyrocketed by 82bps to 4.41% in 2022, then dropped by -22bps to 5.38% in 2023, then rose by 10bps to 4.82% in 2024.
  • Its EBIT Margin was 4.82% in FY2024, compared to 5.38% in FY2023 and 4.41% in FY2022.